Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BOLT · Mar 31, 2024
Bolt Biotherapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-059564General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-317.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
188.83% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-324.08% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
313.41% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
43.65% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesSelf-history eligible
Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/6 normalizedLevel 3Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20245/6 normalizedLevel 3Sep 30, 20245/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20254/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 2.62%
- Current
- 0.00%
- Delta
- -2.62%
- Previous
- -882.75%
- Current
- -317.61%
- Delta
- 565.13%
- Previous
- 37.48%
- Current
- 188.83%
- Delta
- 151.35%
- Previous
- -967.45%
- Current
- -324.08%
- Delta
- 643.37%
- Previous
- 781.39%
- Current
- 313.41%
- Delta
- -467.98%
- Previous
- 117.10%
- Current
- 43.65%
- Delta
- -73.45%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BOLT Fundamental State →Transitioned To · BOLT PROFITABILITY_INCREASED →Transitioned To · BOLT R_AND_D_INTENSITY_DECREASED →Transitioned To · BOLT SBC_INTENSITY_DECREASED →Transitioned To · BOLT Fundamental State →Transitioned To · BOLT CAPEX_INTENSITY_DECREASED →Transitioned To · BOLT CASH_GENERATION_INCREASED →Transitioned To · BOLT GROWTH_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.